• View Cart
  • FAQs
  • LOG IN
Biotech Primer WEEKLY
  • Home
  • Training Options
    • Customized Onsite Training
    • Live, Online 1 & 2-Day Master Courses
    • On-Demand, Online 60-Minute Classes
    • Master Course Recordings
    • Corporate Learning
  • About Us
    • Our Expertise
    • Our Experience
    • Our Clients
    • Contact Us
  • Our Publications
    • The WEEKLY Newsletter
    • 2020 WEEKLY Compendium
    • 2015-2020 Quinquennial
      Compendium
    • Biotech Primer Book
    • Biotech for Non-Scientists Course SnapShot
    • Online Course Snapshot
    • Medical Device Course Snapshot
    • Drug Development Course SnapShot
    • Manufacturing Course SnapShot
Select Page
NASH: A Health Crisis In The Making

NASH: A Health Crisis In The Making

by Emily Burke, PhD | May 26, 2015 | Metabolic & Cardiovascular Disease

The Race Against Nash A silent epidemic creeping upon the Western world pushed the headline grabbing acquisition of a Phase 1 non-alcoholic steatohepatitis (NASH) drug last week. Boehringer Ingelheim (Ingelheim, Germany) acquired Pharmaxis (Sydney, Autralia) due to...

About Biotech Primer

From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.

In a hurry? Take our online classes today.

Subscribe to The WEEKLY

Contact Us | Privacy Policy | Biotech Primer © 2021